Home › Funds › LEUTHOLD GROUP, LLC › REGN

LEUTHOLD GROUP, LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

LEUTHOLD GROUP, LLC reported holding 10,303 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$7.8M, representing 0.73% of its reported portfolio and ranking #49 among its reported holdings. LEUTHOLD GROUP, LLC has disclosed REGN holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)10.30K sh
Reported value held$7.81M
Portfolio Weight0.73%
First reportedQ3 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LEUTHOLD GROUP, LLC's REGN position evolved

LEUTHOLD GROUP, LLC first disclosed a stake in REGN in Q3 2025 at 6,044 shares (US$3.4M). The position peaked in Q3 2026 at 10,303 shares, worth US$7.8M. Across 5 filings, LEUTHOLD GROUP, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 10,303 shares valued at US$7.8M — an increase of 1,038 shares quarter over quarter.. Notable position changes include a 56% increase in Q4 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 6.04K $3.40M New
Q4 2025 9.44K $7.29M Add
Q1 2026 9.78K $7.56M Add
Q2 2026 9.27K $5.78M Reduce
Q3 2026 10.30K $7.81M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has LEUTHOLD GROUP, LLC held REGN?

LEUTHOLD GROUP, LLC has disclosed REGN holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is LEUTHOLD GROUP, LLC's current position in REGN?

As of Q3 2026, LEUTHOLD GROUP, LLC holds 10.30K shares of REGN (REGENERON PHARMACEUTICALS), valued at $7.81M, representing 0.73% of its reported portfolio and ranking #49.

Has LEUTHOLD GROUP, LLC been buying or selling REGN?

In the latest 13F filing (Q3 2026), LEUTHOLD GROUP, LLC increased its position in REGN. The position peaked in Q3 2026 at 10.30K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.